Skip to content
S4028Senate2023-2024 Session

Cap High-Cost Drug Pharmacy Payments

Official title

“Determines the amount paid to a pharmacy for certain high cost drugs”

Sponsor Jessica Scarcella-SpantonSD-23Affects Health
Status
In Senate Committee
Health
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill caps pharmacy payments for certain high-cost drugs at 2.5 percent, plus dispensing fees.

Why it matters

  1. Price threshold. The cap applies to high-cost drugs with a federally set national average acquisition cost above $670.

  2. Payment calculation. Pharmacy payments plus reasonable administrative costs could not exceed 2.5 percent of the drug’s total cost. Authorized dispensing fees would be added separately.

  3. Statewide rule. The bill would override specified existing payment provisions in New York’s Medicaid law and take effect immediately.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Pharmacies dispensing high-cost drugs

    The bill would limit their payments for drugs meeting the federal acquisition-cost threshold.

  • New York State Department of Health

    The health commissioner would determine the reasonable administrative costs included under the cap.

  • Medicaid patients using high-cost drugs

    The bill would change how pharmacies are paid for qualifying prescriptions they receive.

Headline styles

Cap High-Cost Drug Pharmacy Payments

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Jessica Scarcella-Spanton

Senator · Senate District 23

Chair, Veterans, Homeland Security And Military Affairs

No co-sponsors yet.

History

  1. Referred to health
  2. Referred to health

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

4028

2023-2024 Regular Sessions

IN SENATE

February 2, 2023

Introduced by Sen. SCARCELLA-SPANTON -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the social services law, in relation to determining the amount paid to a pharmacy for certain high cost drugs

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Paragraph (b) of subdivision 9 of section 367-a of the social services law is amended by adding a new subparagraph (iv) to read as follows:

(iv) notwithstanding subparagraphs (i) and (ii) of this paragraph and paragraph (e) of this subdivision, if the drug dispensed is a high cost drug and has a national average drug acquisition cost set by the federal center for medicare and medicaid services in excess of six hundred seventy dollars, the actual amount paid to the pharmacy, plus the reasonable administrative costs as determined by the commissioner of health, shall be no more than two and one-half percent of the total cost of such drug, together with any dispensing fee authorized under paragraph (d) of this subdivision.

§ 2. This act shall take effect immediately; provided, however, that the amendments to subdivision 9 of section 367-a of the social services law made by section one of this act shall not affect the expiration of such subdivision and shall be deemed to expire therewith.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD05752-01-3

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the social services law, in relation to determining the amount paid to a pharmacy for certain high cost drugs

Purpose

Provides for a reimbursement for high cost drugs using the federally recognized threshold, medications that cost over $670 must be reimbursed at a rate of NADAC price + 2.5% + the $10.08 dispensing fee

Summary of provisions

Paragraph (b) of subdivision 9 of section 367-a of the social services law is amended by adding a new paragraph (iv) - set high cost drug as having a national average drug acquisition cost set by the federal government for Medicaid/Medicare in excess of $675 the actual amount paid to a pharmacy shall be no more than 2 1/2 % of the total cost, plus reasonable administrative costs and dispending fees.

Existing law

The State Department of Health pays the pharmacist according to a formu- la. Under fee for service, the formula has been streamlined into a "1-size-fits-all approach": NADAC + $10.08. Then, once that amount is calculated, the State "claws back" 1.5% of the total reimbursement.

Justification

Pharmacy drug pricing has become both complicated and convoluted. Essentially, a pharmacist purchases a drug from a wholesaler, holds the drug in inventory until a prescription is presented for that drug. When the patient receives the drug, s/he is responsible for the applicable co-pay (However, if a Medicaid patient claims an inability to pay, the pharmacist must waive it and absorb the loss for prescription to be dispensed). The pharmacist is out the money paid for the drug, and now must purchase the drug to replace it in stock. The pharmacist must then wait for the Medicaid program to pay for the drug that the patient received. The pharmacist is not paid according to the actual price paid for the drug. Rather, the State Department of Health pays the pharmacist according to a formula. Under fee for service, the formula has been streamlined into a "1-size-fits-all approach": NADAC + $10.08. Then, once that amount is calculated, the State "claws back" 1.5% of the total reimbursement

It is unrealistic to ask independent pharmacies, which are also small businesses, to purchase these drugs from wholesalers, stock and provide them to patients, only to lose money. In order to ensure patient access to these needed medications, New Yorkers deserve a tiered pharmacy reimbursement system. Using the federally recognized threshold, medica- tions that cost over $670 must be reimbursed at a rate of NADAC price + 2.5% + the $10.08 dispensing fee. Most importantly, the patients who need these medications will continue to have access.

Legislative history

2021 Session - new bill

Fiscal implications

To be determined

Effective date

This act shall take effect immediately; provided, however, that the amendments to subdivision 9 of section 367-a of the social services law made by section one of this act shall not affect the expiration of such subdivision and shall be deemed to expire herewith.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.